Tolerability, Safety and Immunogenicity Trial of the FLU-M® Tetra

NCT05308212 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

633

Enrollment

OTHER_GOV

Sponsor class

Conditions

Influenza

Interventions

BIOLOGICAL: Flu-M Tetra [Inactivated split influenza vaccine] w/p
BIOLOGICAL: Flu-M Tetra [Inactivated split influenza vaccine] w/o/p
BIOLOGICAL: Ultrix [Inactivated split influenza vaccine]

Sponsor

St. Petersburg Research Institute of Vaccines and Sera